Erlotinib pharmacokinetics: a critical parameter influencing acute toxicity in elderly patients over 75 years-old

Advanced non-Small cell lung cancer patients at the extremes of age in the era of epidermal growth factor receptor tyrosine kinase inhibitors

(2016) Yu-Mu Chen et al.   LUNG CANCER

Low muscle mass is associated with chemotherapy-induced haematological toxicity in advanced non-small cell lung cancer

(2015) Bjørg Sjøblom et al.   LUNG CANCER

Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers

(2015) Chenjie Zeng et al.   JAMA Oncology

Molecular Epidemiology of EGFR Mutations in Asian Patients with Advanced Non-Small-Cell Lung Cancer of Adenocarcinoma Histology – Mainland China Subset Analysis of the PIONEER study

(2015) Yuankai Shi et al.   PLoS One

Role of the lean body mass and of pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of sunitinib in cancer patients

(2014) C. Narjoz et al.   INVESTIGATIONAL NEW DRUGS

Efficacy and safety of erlotinib in elderly patients in the phase IV POLARSTAR surveillance study of Japanese patients with non-small-cell lung cancer

(2014) Hiroshige Yoshioka et al.   LUNG CANCER

Sarcopenia and body mass index predict sunitinib-induced early dose-limiting toxicities in renal cancer patients

(2013) O Huillard et al.   BRITISH JOURNAL OF CANCER

An HPLC-UV method for the simultaneous quantification of vemurafenib and erlotinib in plasma from cancer patients

(2013) Yi Zhen et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Effects of Pharmacokinetic Processes and Varied Dosing Schedules on the Dynamics of Acquired Resistance to Erlotinib in EGFR-Mutant Lung Cancer

(2012) Jasmine Foo et al.   Journal of Thoracic Oncology

Sarcopenia Predicts Early Dose-Limiting Toxicities and Pharmacokinetics of Sorafenib in Patients with Hepatocellular Carcinoma

(2012) Olivier Mir et al.   PLoS One

Drug-Induced Effects on Erlotinib Metabolism

(2011) Olivier Mir et al.   NEW ENGLAND JOURNAL OF MEDICINE

Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma

(2010) S. Antoun et al.   ANNALS OF ONCOLOGY

Erlotinib for Advanced Non–Small-Cell Lung Cancer in the Elderly: An Analysis of the National Cancer Institute of Canada Clinical Trials Group Study BR.21

(2008) Paul Wheatley-Price et al.   JOURNAL OF CLINICAL ONCOLOGY